Alternate site health provider Option Care Health (NASDAQ: OPCH) will be announcing earnings results tomorrow morning. Here’s what to look for.
Option Care Health beat analysts’ revenue expectations by 4.9% last quarter, reporting revenues of $1.35 billion, up 19.7% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts’ full-year EPS guidance estimates and a solid beat of analysts’ EPS estimates.
Is Option Care Health a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Option Care Health’s revenue to grow 9.6% year on year to $1.26 billion, slowing from the 12.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.34 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Option Care Health has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3% on average.
Looking at Option Care Health’s peers in the healthcare providers & services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Chemed delivered year-on-year revenue growth of 9.8%, beating analysts’ expectations by 0.8%, and Centene reported revenues up 15.4%, topping estimates by 8.3%. Chemed traded down 6.9% following the results.
Read our full analysis of Chemed’s results here and Centene’s results here.
The euphoria surrounding Trump’s November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 5.6% on average over the last month. Option Care Health is down 8.2% during the same time and is heading into earnings with an average analyst price target of $38.44 (compared to the current share price of $32.08).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
